Search Results

The Psychemedics Microplate EIA for Oxycodone is an enzyme immunoassay (EIA) for the preliminary qualitative detection of the opiate oxycodone in human head and body hair using an oxycodone calibrator at 2 ng /10 mg hair cutoff for the purpose of identifying oxycodone use. This is an in vitro diagnostic device intended exclusively for Psychemedics use only and is not intended for sale to anyone.

The Psychemedics Microplate EIA oxycodone assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas or Liquid Chromatography/Mass Spectrometry (GC/MS or LC/MS or LC/MS/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

The test consists of two parts; a pre-analytical hair treatment procedure (to convert the solid matrix of hair to a measurable liquid matrix) and the screening assay, the Psychemedics Microplate EIA for Oxycodone. The drug is recovered from the hair using a patented method (U.S. Patent #8,084,215).The screening portion of the test system consists of (1) microplate wells coated with multiple drugs including oxycodone conjugated to bovine serum albumin (BSA) (patent pending), polyclonal rabbit anti-oxycodone, goat anti-rabbit secondary antibody conjugated to HRP (horseradish peroxidase), substrate [3, 3', 5, 5' tetramethylbenzidine (TMB)], HCl to acidify (which stops the reaction), and wash buffer for washing the plates. Absorbance in the wells is read with a microplate reader.

Acceptance Criteria and Device Performance for Psychemedics Microplate EIA for Oxycodone in Hair

The Psychemedics Microplate EIA for Oxycodone in Hair is an enzyme immunoassay for the preliminary qualitative detection of oxycodone in human head and body hair. The device's performance was evaluated through precision studies and agreement testing against LC/MS/MS confirmation.

1. Table of Acceptance Criteria and Reported Device Performance

The direct acceptance criteria for the device are not explicitly stated as numerical targets in the provided document. However, the performance is reported in terms of precision (intra-assay and inter-assay agreement at various concentrations relative to the cutoff) and agreement with the confirmatory method (LC/MS/MS). The implied acceptance criteria are high agreement percentages for both positive and negative samples around the cutoff.

• Positive (plus 25%, plus 50%, plus 75%, plus 100%): 15/15 reported as POS |
  | Precision (Inter-Assay) | High agreement for negative and positive samples at various levels relative to the 2 ng/10 mg hair cutoff. | - Negative (B0, -75%, -50%, -25%): 75/75 reported as NEG
• Positive (plus 25%, plus 50%, plus 75%, plus 100%): 75/75 reported as POS |
  | Agreement with LC/MS/MS | High concordance between EIA results and LC/MS/MS confirmation, especially for samples around the cutoff. | - **47 Negative HC/MS/MS samples (

Ask a specific question about this device